Compare CVS Health Corp (CVS) vs Hershey Co (HSY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Hershey Co — how do they compare? CVS Health Corp trades at $85.46 (market cap $112.29B), while Hershey Co trades at $162.52 (market cap $32.66B). The key difference: CVS Health Corp is far larger — about 3.4× Hershey Co's market cap, and Hershey Co pays the higher dividend (3.57%). Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Hershey Co for 135 Days on average.
| CVS | HSY | |
|---|---|---|
Market Cap | $112.29B | $32.66B |
Volume | 7,763,676 | 1,578,237 |
Sector | Health | Consumer Staples |
52-Week High | $110.60 | $236.28 |
52-Week Low | $70.08 | $157.61 |
Typical Hold Time | 83 Days | 135 Days |
Enterprise Value | $174.64B | $37.79B |
Dividend Yield | 3.03% | 3.57% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.95, up 1.76% with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 26% upside. Recent quarterly earnings consistently beat expectations, with Q2 2026 EPS of $2.58 surpassing the $1.85 estimate. Revenue growth remains solid at $402.07 billion for 2025, though net margins compressed to 1.18%. Technical indicators show a bullish overall signal with support at $87 and resistance at $89.
The outlook remains positive given CVS's dominant market position and Medicare expansion plans, but investors face risks from reimbursement pressures and ongoing legal investigations. Earnings growth and successful execution of healthcare services integration represent the primary catalysts for continued stock appreciation.
Hershey (HSY) trades at $160.34, down 0.29% on the day, with a bearish technical signal from moving averages. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 results pending. Strong profitability metrics include a 32.81% ROE and 12.24% net margin, though 2025 net income declined significantly from 2024 levels. Recent corporate developments include new international leadership and ongoing brand investment initiatives.
The stock presents a mixed outlook with 26% upside to the consensus price target of $204.62, but faces headwinds from cocoa cost pressures and technical weakness. While dividend growth has resumed after a nearly two-year freeze, investors should weigh strong brand positioning against commodity volatility and declining institutional holdings in recent quarters.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Hershey Co
Hershey is a leading confectionery manufacturer in the U.S. (around a $25 billion market), controlling around 46% of the domestic chocolate space (per IRI). Beyond its namesake label, the firm's mix has expanded over the last 85 years and now consists of 100 brands, including Reese's, Kit Kat, Kisses, and Ice Breakers. Hershey's products are sold in about 80 countries, albeit with just a high-single-digit percentage of sales coming from markets outside the U.S., including Brazil, India, and Mexico. The firm has sought inorganic opportunities to extend its reach beyond its core confection business, adding Amplify Snack Brands and its Skinny Pop ready-to-eat popcorn to its mix and Pirate Brands (including the Pirate's Booty, Smart Puffs, and Original Tings brands) over the past few years.
Read more on HSY →
